Breast cancer can spread to the layers of tissue that line and protect the brain, called leptomeningeal disease (LD). Click to learn about current research studying how to treat and manage LD.
Treatment resistance is when cancer does not respond to a drug. Read about research studying why resistance happens and how to overcome resistance.
Lobular breast cancer is difficult to detect with imaging scans. Researchers are studying a new method to improve detecting lobular breast cancer when it spreads. Read more here.
Researchers are working to understand the complex reasons for differences in MBC outcomes. Understanding these differences could allow for more personalized treatment. Learn more here.
Over time, people may develop resistance to CDK4/6 inhibitors, which means the drugs stop working. Learn about new strategies being studied in clinical trials to overcome resistance.
Learn about FGFR and what genetic abnormalities in FGFR mean for you and your MBC.
Learn more about a different way of giving chemotherapy
